|
NUP50 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.345200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.654200E-01 |
| Normal-vs-Stage2 |
9.230200E-01 |
| Normal-vs-Stage3 |
3.075800E-01 |
| Normal-vs-Stage4 |
6.671600E-01 |
| Stage1-vs-Stage2 |
9.407200E-01 |
| Stage1-vs-Stage3 |
2.085600E-01 |
| Stage1-vs-Stage4 |
5.657200E-01 |
| Stage2-vs-Stage3 |
5.044600E-01 |
| Stage2-vs-Stage4 |
6.616200E-01 |
| Stage3-vs-Stage4 |
1.489230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.721800E-01 |
| Normal-vs-AfricanAmerican |
3.213600E-02 |
| Normal-vs-Asian |
1.378610E-01 |
| Caucasian-vs-AfricanAmerican |
1.869880E-02 |
| Caucasian-vs-Asian |
1.824020E-01 |
| AfricanAmerican-vs-Asian |
2.199700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.839200E-01 |
| Normal-vs-Female |
9.001000E-01 |
| Male-vs-Female |
8.691600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.191200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.126200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.205400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.098190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.343000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.286200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.570200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.757450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.781500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.007600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.316600E-01 |
| Normal-vs-Grade 2 |
7.312200E-01 |
| Normal-vs-Grade 3 |
4.395600E-01 |
| Normal-vs-Grade 4 |
5.577400E-01 |
| Grade 1-vs-Grade 2 |
5.709600E-01 |
| Grade 1-vs-Grade 3 |
2.363000E-01 |
| Grade 1-vs-Grade 4 |
3.585600E-01 |
| Grade 2-vs-Grade 3 |
1.440960E-01 |
| Grade 2-vs-Grade 4 |
3.278000E-01 |
| Grade 3-vs-Grade 4 |
9.906000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.923400E-01 |
| Normal-vs-ccB subtype |
5.023200E-01 |
| ccA subtype-vs-ccB subtype |
2.613500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.479400E-01 |
| Normal-vs-N1 |
5.728000E-01 |
| N0-vs-N1 |
4.679000E-01 |
|
|
